Drugs and Devices

FDA approves new drug for irritable bowel syndrome and constipation

On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares